Avobenzone 3%, Homosalate 10%, Octocrylene 6%
Over-the-Counter상품명: Rubber Ducky SPF 50 Unfragranced Sunscreen
About This Medication
Topical product applied to the skin for localized treatment and symptom relief.
유효 성분
| 성분 | 함량 |
|---|---|
| Avobenzone | - |
| Homosalate | - |
| Octocrylene | - |
적응증 및 용법
용량 및 투여 방법
경고 및 주의 사항
Warnings For external use only . Do not use on damaged or broken skin. When using this product keep out of eyes. Rinse eyes with water to remove. Stop use and ask a doctor if rash occurs.
Frequently Asked Questions
Directions Apply liberally 15 minutes before sun exposure. Reapply: after 80 minutes of swimming or sweating immediately after towel drying at least every 2 hours Sun protection measures: spending time n the sun increases your risk of skin cancer and early skin aging. To decrease risk, regularly use a sunscreen with broad spectrum SPF of 15 or higher and other sun protection measure including: limit time in the sun, especially from 10 am to 2 pm wear long-sleeved shirts, pants, …
Uses Helps prevent sunburn. If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.
Warnings For external use only . Do not use on damaged or broken skin. When using this product keep out of eyes. Rinse eyes with water to remove. Stop use and ask a doctor if rash occurs.
Avobenzone 3%, Homosalate 10%, Octocrylene 6% is available over the counter (OTC) without a prescription.
Similar Topical Products
Browse all Topical products →References & Data Sources
- • DailyMed — Avobenzone 3%, Homosalate 10%, Octocrylene 6% drug label (National Library of Medicine)
- • openFDA — Avobenzone 3%, Homosalate 10%, Octocrylene 6% label data (U.S. Food & Drug Administration)
- • NDC Directory — Avobenzone 3%, Homosalate 10%, Octocrylene 6% (FDA National Drug Code)
의료 면책 조항
이 페이지의 정보는 교육 목적으로만 제공되며, 전문적인 의학적 조언, 진단 또는 치료를 대체하는 용도로 사용해서는 안 됩니다.
의학적 상태나 의약품에 관한 질문이 있으시면 반드시 의사 또는 자격을 갖춘 의료 전문가에게 조언을 구하시기 바랍니다.
데이터 출처: DailyMed (NLM), openFDA, MFDS